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Abstract 
A single high-fat meal (HFM) can increase systemic inflammation (postprandial 
inflammation; PPI) and may be attenuated by recent exercise. However, the effect of 
preprandial exercise on PPI in older adults (OA) is not clear. Purpose: To determine if 
preprandial exercise attenuates PPI in YA and OA. Methods: 12 YA (23.3±3.9 years n= 5 
M/7 F) and 12 OA (67.7±6 years, n= 8 M/4 F) completed two HFM challenges in a 
randomized order. During HFM alone, participants abstained from exercise 48 hours prior 
to the HFM session (except for the exercise session) and adhered to a 12 hour overnight 
fast. Baseline measurements were taken immediately before participants consumed the 
HFM (12 kcals/kg BW: 57% fat, 39% CHO, 4% PRO), and then again three and six hours 
postprandially. In exercise + HFM (EX+HFM) participants performed exercise at a heart 
rate that corresponded to 65% VO2Peak until caloric expenditure matched 75% of the caloric 
content of the HFM, then adhered to a 12 hour overnight fast before consuming the HFM. 
Results: All markers of inflammation were lower at three hours postprandially regardless 
of condition or age (p<0.05). Furthermore, IL-10 (93% of baseline) and TNFα (88% of 
baseline) remained below baseline concentrations at six hours (p<0.05) while IL-6, IL8, 
and IL-1β increased back to baseline levels (p>0.05). TNFα was greater in OA at baseline 
compared to YA (p<0.05), but not at three or six hours postprandially (p>0.05). There was 
no difference in inflammation between HFM and EX+HFM at any time point (p>0.05). 
Conclusion: Contrary to our hypotheses, a HFM did not elicit PPI in YA or OA. 
Additionally, exercise did not impact inflammation at any timepoint.  Future work should 
be performed on the PPI response and the effect of preprandial exercise on individuals 
already afflicted with inflammation related diseases.  
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Chapter I 
Western Diet 
 The typical western diet consists of nutrient poor and calorically dense foods, 
including red meats, simple refined carbohydrates, and saturated or trans fats. Research 
into the potential health risks of the western diet has increased over the past decades in 
reaction to the increased prevalence of lifestyle disease in the American population1. 
Specifically, the prevalence of obesity, cardiovascular disease, hypertension, and type II 
diabetes has increased in tandem with the proliferation of chronic high-fat and high calorie, 
westernized diets2. While the negative health effects from chronic westernized diets have 
been well characterized and may extend beyond obesity3, the adverse health effects of 
regular high-fat meals may arise prior to the onset of obesity.  It is likely that there are 
adverse metabolic and immune responses result from a single high-fat, westernized meal3–
5. Research has shown the influence of a single HFM on complex physiological functions6 
(i.e. inflammation, immune system, metabolism), which provides insights into the 
mechanistic role a chronic westernized diet has on the risk of metabolic and cardiovascular 
disease development. A key mechanism initiating the development of chronic diseases may 
be the prolonged activation of innate and acquired immune pathways.  
Innate Immune System and Inflammation 
 The innate immune system is the first response to tissue damage or the presence of 
invading antigens7. Activation of the innate immune system is characterized by the 
mobilization of neutrophils, macrophages8, and natural killer (NK) cells9 .  These cells 
engulf the pathogens to be destroyed within the cell or secrete other proinflammatory 
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cytokines to mediate additional inflammatory effects8. Interleukin-6 (IL-6) is a pro-
inflammatory cytokines that recruits T cells and B cells from the acquired immune system 
to aid in managing invading pathogens10. 
Inflammation is a complex, multi-regulated, physiological response to tissue 
damage or invading pathogens11. Classical inflammation is associated with swelling and 
tenderness from a laceration or damaged muscles that is easily visible and causes 
discomfort. However, classical inflammation is not an urgent problem for most people and 
is resolved by the coordination of innate immune responses and tissue healing within days 
of injury. Inflammation can also be caused by invading pathogens, which provoke an acute 
inflammatory response at a subclinical level. Regular exposure to such pathogens results 
in the prolonged presence of pro-inflammatory cytokines involved in the subclinical 
response and promotion of a state of persistent low-grade, systemic inflammation. It 
appears that this type of chronic, low-grade systemic inflammation plays a detrimental role 
in human health.  The presence of low-grade inflammation has been associated with 
increased risk of cardiovascular disease12,13, vascular diseases14, atherosclerosis15,  type II 
diabetes16, Alzheimer’s disease17, and various cancers18,19. 
Damage to the vascular tissue by penetration of pathogens triggers an innate 
immune response and a pro-inflammatory cascade that begins with monocytes arriving at 
the site of endothelial cell activation. Monocytes enter vascular tissue around activated 
endothelial cells and differentiate into macrophages20 which absorb circulating pathogens 
in an effort to prevent further damage. Working macrophages subsequently secrete two 
types of acute phase inflammatory proteins, interleukin-6 (IL-6) and tumor necrosis factor-
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α21 (TNF-α). IL-6 and TNF-α are two upstream mediators that further contribute to the pro-
inflammatory cascade22,23. 
IL-6 is a multifunctional, polypeptide protein hormone24. Depending on the 
interaction of IL-6 with either IL-6 receptor (IL-6R) or soluble IL-6 receptor (sIL-6R) 25,26, 
IL-6 can mediate either a pro or ant-inflammatory response. During an innate immune 
response, IL-6 is synthesized and secreted from active pro-inflammatory M1 macrophages. 
As a pro-inflammatory cytokine, IL-6 is the key regulator of secondary acute phase 
inflammatory protein synthesis in the liver, such as c-reactive protein27 (CRP), a marker of 
chronic inflammatory. 
IL-6 also contributes to creating an environment that is more prone to chronic 
inflammation26. Prolonged secretion of IL-6 stimulates more IL-6 synthesis and secretion, 
as well as B cell differentiation, T cell activation, and immunoglobulin secretion26. This 
leads to an increase in monocyte recruitment which then stimulates secretion of IL-8 and 
monocyte chemoattractant protein 1 (MCP-1)28. MCP-1 stimulates the recruitment of 
additional monocytes, which differentiate into inflammatory macrophages within the 
vascular tissue29. The shift to more tissue resident macrophages creates an environment 
that can more easily promote inflammation via IL-6 and TNF-α synthesis and secretion26,30. 
TNF-α is regulated by nuclear factor-kappa-B (NF-kB) and mediates inflammation 
by modifying endothelial leukocyte function. These cells exhibit altered combinations of 
leukocyte adhesion molecules E-selectin, vascular  cell adhesion molecule-1(VCAM-1), 
and intercellular adhesion molecule-126 (ICAM-1). ICAM-1 and VCAM-1 are essential in 
promoting macrophage infiltration into vascular and adipose tissue. ICAM-1 and VCAM-
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1 also increase the rate at which inflammatory cytokines adhere to the endothelium, which 
contributes to the development and progression of atherosclerosis. 
Inflammation is a complex process involving collaborating systems, cytokines, and 
molecules. Chronic inflammation is achieved through continued activation of acute 
inflammation responses. These consequences of regular acute inflammation creates an 
environment of chronic, low-grade inflammation and highlights the importance of 
minimizing exposure to inflammatory stimuli. A frequent HFMs may be a stimuli for such 
consequences, and lead to chronic inflammation process through repeated increases in 
postprandial lipemia and acute inflammation. 
Postprandial Lipemia and Inflammation 
 High and/or moderate fat meals consisting of 0.4-1.5 g of fat/kg bw can elicit a 
significant increase in postprandial lipemia31 (PPL), typically measured through blood 
triglyceride (TG) concentrations. Even a single HFM increases circulating triglycerides 
and very low density lipoprotein (VLDL) concentration. Elevated levels of TG cause a 
decrease in high density lipoproteins (HDL) and an increase in low density lipoproteins32 
(LDL). LDLs are a smaller, denser derivative of VLDLs, formed as a result of the 
breakdown of circulating triglycerides. LDLs can penetrate endothelial cells of the vascular 
wall and initiate the inflammatory cascade previously mentioned33. Vascular tissue 
penetration and endothelial cell activation has an immediate detrimental effect on 
endothelial function34. The buildup of plaque on vascular walls enables greater monocyte 
penetration, ultimately contributing to an environment that promotes inflammation. 
Frequent consumption of 2-3 HFMs a day by many individuals means that they spend much 
of the day in a state of postprandial lipemia and inflammation. 
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 Chronic, low-grade systemic inflammation has been reported to increase due to a 
Westernized lifestyle. The scale of the postprandial inflammatory response after a single 
HFM is dependent on the percent of saturated and trans fat within the meal as well as its 
caloric density. Typical western meals contain approximately 20-40 grams of saturated fat. 
Absolute saturated and trans fat content of 30-50 grams in a single meal causes significant 
increases in circulating triglycerides35 (known as postprandial lipemia (PPL)) and possibly 
postprandial inflammation (PPI) as a result of PPL. HFMs with relative saturated and trans 
fat content in a meal of at least 60% also cause PPL and PPI.  
Variations in Postprandial Inflammatory Responses 
A wide range of macronutrient ratios have been used in PPI research. Increases in 
IL-6 have been observed with fat percentages as low as 30% of the meal36, while meals 
with up to 85% of the macronutrients from fat and have seen similar responses in 
postprandial IL-6 concentrations37. Absolute versus relative total calories consumed is also 
a factor in the PPI. There is substantial variation in absolute calorie content between meals 
in the literature, ranging from 60038 kilocalories39,40 (kcals) to over 1470 kcals41. 
Kračmerová and colleagues used a HFM containing over 1470 kcals with 46% fat, resulting 
in significant increases in IL-6 and increased mRNA expression of TNF-α, MCP-1, and 
other inflammatory markers such as IL-1β, and IL-8 in young healthy men. In contrast, 
Drew and colleagues implemented a HFM containing 600 kcals with 50% fat and reported 
increases in IL-6 and TNF-α that were 7% greater than those of Kračmerová and 
colleagues. Relative caloric content is also commonly used in HFM challenges, because it 
is more applicable to real-world eating habits. Results for HFMs relative caloric content 
are consistent with those of the absolute caloric content42,43. Even though HFMs consisting 
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of large absolute caloric content elicit large pro-inflammatory changes in IL-6 and possibly 
TNF-α, more realistic meals with relative caloric content still elicit significant pro-
inflammatory responses, though findings have been mixed.  
It is understood that PPI may be dependent on the type of fat, the percentage of fat 
in the meal, and the relative versus absolute calories consumed. However, recent studies 
have also suggested that chronic physical activity level and participation in acute exercise 
may be an important consideration in reducing chronic low-grade systemic inflammation 
and acute PPI44.  
The Effect of Exercise on Postprandial Inflammation 
 Exercise is a natural anti-oxidant45 and anti-inflammatory46, and therefore may 
induce a systemic attenuation of PPI. The potential attenuation of PPI from exercise could 
occur through several mechanisms. Exercise can act indirectly on PPI through mitigation 
of the  lipemic pathway of inflammation, through reduction of PPL via circulating LDL 
through 47 and/or increased plasma VLDL clearance48, or by up-regulation of lipoprotein 
lipase levels (LPL) at the skeletal muscle48, and increased lipid hydrolysis. LDL will 
decrease as a result of these attenuations in VLDL, which will reduce scale of endothelial 
activation and inflammation response. Alternatively, exercise can elicit a direct anti-
inflammatory state through increased anti-inflammatory cytokine secretion7.  
Post exercise reductions in plasma VLDL levels results in decreased LDL 
concentration and potential for endothelial activation. Moderate intensity exercise (60% 
VO2MAX) performed the afternoon before a morning HFM has been shown to reduce 
postprandial VLDL clearance by 40%, but not hepatic secretion48. Additionally, there 
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appears to be a nonlinear dose response to exercise’s effect on VLDL dynamics. The effect 
of an acute one hour moderate intensity cycling (60% VO2MAX) bout had a lesser effect on 
VLDL levels compared to a 90 minute exercise session49, and changes in VLDL levels 
nearly plateau as exercise exceeded two hours50,51. Exercise induced caloric deficit may 
provide be the mediator for eliciting decreases in VLDL levels. Additionally, a threshold 
caloric deficit of 500 kcals may exist, as there is minimal or absent reductions in VLDL 
concentrations when energy expenditure is less than 500 kcals52. However, inconsistencies 
in changes in VLDL at this low caloric expenditure might suggest the need for a relative 
caloric expenditure threshold, additional research needs to be conducted to confirm this 
idea. The introduction of regular exercise in previously sedentary, healthy individuals as 
well as type II diabetics decreases hepatic VLDL secretion47. This suggests a protective 
benefit of chronic exercise. Exercise of similar duration and intensity needed to alter 
hepatic VLDL secretion also increases LPL activity 8-22 hours after exercise53. Greater 
mass and activity of LPL at the muscle and endothelial membrane upregulates lipoprotein 
hydrolysis and reduces circulating lipoproteins52. 
Regular physical activity appears to reduce fasting pro-inflammatory IL-6 levels in 
healthy middle aged men for at least 24 hours after an individual’s last exercise bout. 
However, postprandial IL-6 levels are no different between regularly active and inactive 
men54 when exercise is abstained for 24 hours. This indicates that there might be a narrow 
time frame for the direct anti-inflammatory effects of exercise. Working skeletal muscles 
secrete anti-inflammatory IL-6 in concentrations up to 100 times greater than fasting levels 
55,56. Prolonged muscle contraction57 and the depletion of muscle glycogen stores58 appear 
to be the main stimulus for increases in anti-inflammatory IL-6. IL-6 freely enters the 
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bloodstream after secretion from skeletal muscle, eliciting a systemic effect predominantly 
mediated by inhibiting the release of pro-inflammatory cytokines TNF-α and IL-1 in 
addition to upregulating the production of anti-inflammatory interleukin-10 (IL-10).  
 Circulating IL-10 mediates many of the systemic anti-inflammatory benefits of 
exercise59. IL-10 directly downregulates pro-inflammatory cytokines and inhibits 
production of ICAM1 which both reduce pro-inflammatory capacity60. Additionally, IL-
10 down regulates macrophage concentrations and also reduce macrophage penetration 
into adipose and muscular cells in mice trials61. Thus, exercise can have a large and 
systemic anti-inflammatory response that directly counteracts multiple pro-inflammatory 
pathways. 
Exercise Prescriptions for Attenuating PPI  
 Due to the link between PPL and PPI, the ability of exercise to attenuate the increase 
in postprandial circulating TG indicates its effectiveness at also attenuating PPI as well as 
increased anti-inflammatory IL-6 and IL-10 production. Research into type, duration, and 
intensity of exercise show that certain modalities and prescriptions are more effective than 
others31. In a review by Freese and colleagues, low to moderate intensity exercise (d = -
0.58; P < 0.0001) and high intensity interval exercise (>90% VO2Max) (d = -1.49; P < 
0.0001) both significantly reduced PPL31 with high intensity interval exercise having the 
largest impact. In contrast, resistance training did not significantly reduce PPL (d = -0.13; 
P < 0.01)31. Yet, the effect that exercise duration and intensity have on PPL and PPI is 
based on the caloric deficit they produce6. 
 
9 
 
 
 
 Additionally, the magnitude of the exercise induced caloric deficit varies widely in 
the literature. Both absolute and relative energy expenditures are used to prescribe 
preprandial and postprandial exercise. However, Katsanos and Moffatt suggest attenuation 
of PPL is most commonly observed with preprandial exercise that reaches an energy 
expenditure threshold of at least 500 kcals62. Several studies have utilized acute exercise 
bouts where energy expenditures were over 1000 kcals. While these types of exercise bouts 
elicit the greatest reductions in PPL, the intensity and duration of exercise to reach 1000 
kcals is not feasible for most people and may not be true to life. To improve PPL and PPI 
outcomes, but keep exercise realistic for most individuals, recent studies employ exercise 
where caloric expenditure is in the range of 600-900 kcals, which may still attenuate PPL 
and PPI. 
Older Adults and Inflammation? 
 Systemic, low-grade inflammation, termed inflammaging, increases through the 
aging process12,63. In addition, the immune system gradually deteriorates with age, known 
as immunosenescence. Immunosenescence worsens the immune system’s response time 
and effectiveness when pathogens are present, increasing susceptibility to disease and 
illness12. A life time of poor lifestyle choices, including sedentary behavior and poor 
dietary choices, results in more frequent exposure to various pathogens64. Prolonged 
pathogen exposure may elicit subclinical inflammatory responses which mediate 
inflammaging43 and cause greater damage to tissues and cells. In a 10 year longitudinal 
study of 249 male and female older subjects age 67.5 + 2.4 years old, Bartlett and 
colleagues reported significant increases in IL-6, TNF-α, and CRP63. Additionally, there 
was a significant decrease in IL-10, indicating not only increased inflammation via greater 
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concentrations of pro-inflammatory cytokines, but also through a reduction in anti-
inflammatory mediators. 
Similar to low-grade, systemic inflammation that is not associated with age, 
inflammaging is also strongly associated with diseases commonly seen in older 
populations64. However, despite the growing numbers of older Americans, little research 
has been done to determine the impact of a HFM on those 60 and older65,66. Inflammation 
may magnify the normal PPI response observed in young adults. Furthermore, substantial 
decreases in skeletal muscle mass and resting IL-10 levels suggest a decreased ability to 
upregulate anti-inflammatory cytokines. Thus, the effect that acute and chronic exercise 
have on PPI in young adults may vary when compared to older adults. 
Purpose and Hypotheses 
The purpose of this study is to determine whether an acute bout of preprandial 
exercise attenuates the PPI response after a HFM in young and older adults. We 
hypothesize that (1) an acute bout of physical activity will attenuate the postprandial 
inflammatory response in young and older adults, (2) older adults will experience a greater 
attenuation from acute exercise than young adults. 
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Chapter II 
Methods 
Subjects 
Twenty-four subjects will be recruited for this study, of which there will be twelve 
young adults between 18-35 years (n= 5 M / 7 F) and 12 older adults between 60-80 years 
(n= 8 M/ 4 F). Subjects will be asked to complete a physical activity readiness 
questionnaire (PAR-Q) to determine whether they are eligible to enroll in the study. They 
also will complete the international physical activity questionnaire (I-PAQ) to determine 
chronic physical activity level to estimate physical activity in MET-minutes/week. 
Experimental Design 
 Each subject will complete a total of four laboratory visits. On the first visit, initial 
baseline measures of height, weight, bodyfat percentage, and blood pressure will be taken 
and VO2Peak will be determined. Subjects will then be randomly assigned an order to 
perform two HFM challenges, either the HFM alone (HFM) or a HFM challenge with a 
preprandial exercise session twelve hours prior to the meal (EX + HFM) that will be 
conducted in the same lab. The experimental design can be seen displayed in Figure 1, 
below.  
Initial Measurements 
The first laboratory visit will be used to collect baseline measurements. Height will 
be taken with a stadiometer (Charder Model HM 200P, Charder Electronic Co Ltd., 
Taichung, Taiwan) and weight with a standard physician’s scale (Dymo Pelouze model 
4040, Newell Brands, Hoboken, NJ) to calculate body mass index. Following height and 
weight, a dual-energy x-ray absorptiometry (DEXA) (GE Lunar iDXA Fairfield, CT) scan 
 
12 
 
 
 
will be performed to calculate lean mass, fat mass, and percent body fat. Resting blood 
pressure (BP) will be taken immediately after the DEXA is completed, so that the subject 
will have been resting for at least five minutes. BP will be measured using an automatic 
Sphygmomanometer (ProBP 3400 Welch Allyn, Skaneateles Falls, NY) as detailed in 
American College of Sports Medicine (ACSM) Guidelines. The average of the two BP 
measurements will be recorded. Waist circumference will be taken at the narrowest part of 
the waist with a Gulick tape measurer (Creative Health Products, Ann Arbor, MI). 
Maximal Exercise Testing  
An incremental cycling test to exhaustion will be performed on a VIAsprint 150P 
cycle ergometer (Vyaire Medical, Mettawa, IL) to determine VO2Peak. Expired air will be 
analyzed by a Vmax Encore metabolic cart (Vyaire Medical, Lake Forest, IL), while heart 
rate (HR) will be measured by a Polar Link heart rate strap and watch (Polar Lake Success, 
NY). Once the headset, mouthpiece, and nose plug are fitted the subjects will complete a 
five minute warm up at a self-selected cadence >50 revolutions per minute (rpm). During 
the warm up, power output will be either increased or decreased every minute until subjects 
identify a workload, they perceived as maintainable for approximately thirty minutes.  
Based on the power output determined during the warm up, one of four potential 
test protocols will be chosen (Table 1) in order to reach VO2Peak. Immediately after the 
warm up, the incremental test will begin, and wattage will be set according to stage one of 
the selected protocol. Resistance will then be increased every minute based on the protocol 
being used (10 Watts or 25 Watts). Subjects will be verbally encouraged to continue 
pedaling by the investigators throughout the exercise test. The test will be terminated when 
subjects reach volitional exhaustion.  
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Food Log and ASA24 Food Recall 
Subjects will be given a food log and instructed to record, in detail, all foods and 
beverages consumed the day before their HFM Challenge. For the second HFM Challenge, 
subjects will be asked to duplicate their diet from the previous HFM Challenge as closely 
as possible, and once again record in detail their diet for that day.  
Preprandial Exercise Bout 
 During the EX + HFM trial, subjects will perform an acute exercise bout twelve 
hours prior to their HFM challenge on the VIAsprint 150P cycle ergometer (Vyaire 
Medical, Mettawa, IL), which was previously used for the VO2Max test. Wattage will be set 
so that subjects’ HR stays within a HR range that corresponds to 60-70% of their VO2Peak 
HR, for a duration long enough to achieve a total energy expenditure equivalent to 75% of 
the calories of the HFM challenge (Equation 1). However, subjects will not be permitted 
to exercise longer than 2-hours. After the exercise bout, subjects will be asked to adhere to 
the same 12 hour overnight fast as they would for the non-exercise trial. 
HFM Composition 
Subjects will be asked to adhere to an overnight twelve hour fast before consuming 
the HFM which will consist of a slice of Marie Callender's Chocolate Satin Pie (Conagra 
Brands, Chicago, IL) portioned out to a caloric density of 12 kcals/kg bw. Macronutrient 
composition of the HFM will be 57% fat (57% of which is saturated fat), 4% PRO, and 
39% CHO.  
HFM Challenge Day 
After reporting to the lab, subjects will be seated in a reclining chair for the duration 
of the HFM session. After resting for at least five minutes before two baseline BP 
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measurements will be taken with at least 30 seconds of rest between each recording. An 
indwelling safelet catheter will be inserted into a forearm vein via a 22-gauge needle 
(Fisher Scientific, Waltham, MA) and kept patent with a 0.9% NaCl solution with a drip 
rate of one/second. A fasting blood draw will be taken once the catheter is in place via a 5 
mL syringe (BD) and emptied into a 6-mL EDTA-coated vacutainer tube. Subjects’ satiety 
will then be recorded via the satiety labeled intensity magnitude (SLIM) Satiety Scale. 
Following the baseline blood draw and SLIM rating, subjects will have 20 minutes to 
consume the HFM.  
Minimal movement will be allowed for the duration of the six hours after 
consumption. The subject will not be allowed to stand up except for inside the restroom. 
At every hour postprandially, subjects’ satiety will be recorded by the SLIM scale. Blood 
draws will be taken to assess inflammatory markers at baseline, three hours, and six hours. 
The experimental protocol is pictured in Figure 1. 
 Blood samples will be drawn every 30 minutes postprandially until the two hour 
mark at which point draws will be performed every hour. Plasma (for inflammatory 
markers), and blood glucose and lipids (Cardiochek Plus Analyzer, PTS Diagnostics, 
Indianapolis, IN) will be tested prior to the HFM challenge. Plasma samples will be taken 
at baseline, 3, and 6 hours. Blood glucose will be tested every 30 minutes up to 2 hours 
postprandial, and then every hour. Blood lipids will be tested every hour from baseline 
until 6 hours post-prandially. 
Cytokine Analysis 
After blood draws, samples will be transferred to six ml BD vacutainers and 
immediately centrifuged for 12 minutes at 1800 x g and four degrees Celsius. After being 
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separated blood plasma will be aliquoted into 0.5 ml microtainers and stored for later 
investigation in a freezer at -80 C. All plasma samples will be assayed at Eve Technologies 
(Calgary, Alberta, Canada). For this study, a Human High Sensitivity T-Cell Discovery 
Array 14-plex (HDHSTC14) will be used to measure IL-6, IL-1β, IL-8, IL-10, and TNF-a. 
Biomarkers will be analyzed in duplicate and the average measurement will be used for 
analysis of coefficient of variance for each analyte. 
Statistical Analysis 
Statistical analysis will be done with IBM SPSS Statistics v26.0 (IBM Corporation, 
Armonk, NY). To determine statistical significance with 80% power at an alpha level of 
0.05 for determining differences in postprandial triglycerides based on age and activity 
level, five participants will be needed. However, 12 participants will be recruited in each 
group to detect changes in inflammatory responses. All data will be checked for normality 
before analysis using the Shapiro-Wilk test. When data is not normally distributed, it will 
be log-10 transformed and checked again for normality. A mixed factorial analysis of 
variance (ANOVA) will be done with the within-subjects’ factor of time (baseline, three, 
and six hours for cytokines) and condition (HFM or EX+HFM) and the between subjects’ 
factor of age (YA and OA) and if significant main effects of group or time are detected, 
first data will assessed to determine significance as a linear or quadratic function. Next, 
post hoc multiple comparisons will be conducted to test for group- or time-specific 
differences. In this instance, Bonferroni adjustment for multiple comparisons will be 
implemented to avoid type I error. Pearson’s r comparisons will be also be performed to 
assess associations between PPL and PPI. For all analyses, significance will be set to 
p<0.05.  
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Chapter III 
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Abstract 
A single high-fat meal (HFM) can increase systemic inflammation (postprandial 
inflammation; PPI) and may be attenuated by recent exercise. However, the effect of 
preprandial exercise on PPI in older adults (OA) is not clear. Purpose: To determine if 
preprandial exercise attenuates PPI in YA and OA. Methods: 12 YA (23.3±3.9 years n= 5 
M/7 F) and 12 OA (67.7±6 years, n= 8 M/4 F) completed two HFM challenges in a 
randomized order. During HFM alone, participants abstained from exercise 48 hours prior 
to the HFM session (except for the exercise session) and adhered to a 12 hour overnight 
fast. Baseline measurements were taken immediately before participants consumed the 
HFM (12 kcals/kg BW: 57% fat, 39% CHO, 4% PRO), and then again three and six hours 
postprandially. In exercise + HFM (EX+HFM) participants performed exercise at a heart 
rate that corresponded to 65% VO2Peak until caloric expenditure matched 75% of the caloric 
content of the HFM, then adhered to a 12 hour overnight fast before consuming the HFM. 
Results: All markers of inflammation were lower at three hours postprandially regardless 
of condition or age(p<0.05). Furthermore, IL-10 (93% of baseline) and TNFα (88% of 
baseline) remained below baseline concentrations at six hours (p<0.05) while IL-6, IL8, 
and IL-1β increased back to baseline levels (p>0.05). TNFα was greater in OA at baseline 
compared to YA (p<0.05), but not at three or six hours postprandially (p>0.05). There was 
no difference in inflammation between HFM and EX+HFM at any time point (p>0.05). 
Conclusion: Contrary to our hypotheses, a HFM did not elicit PPI in YA or OA. 
Additionally, exercise did not impact inflammation at any timepoint.  Future work should 
be performed on the PPI response and the effect of preprandial exercise on individuals 
already afflicted with inflammation related diseases. 
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Introduction 
The typical western diet consists of nutrient-poor and calorically-dense foods, 
much of which include meals high in saturated and trans fats (high-fat meals; HFMs).  In 
addition, individuals may consume 2-3 HFMs a day, which means that they spend the 
majority of the day in the postprandial state of a HFM. The negative health effects of 
chronic high-fat diets may include obesity, type II diabetes, cardiovascular disease (CVD) 
and other chronic diseases. A key mechanism initiating the development of chronic 
diseases may be the prolonged activation of the innate immune system brought on by 
postprandial lipemia (PPL), mainly the elevated levels of low density lipoproteins (LDLs) 
in circulation after a HFM. Circulating LDLs cause damage to vascular tissue when they 
penetrate the endothelial cells1. An inflammation response is launched to remove the LDLs. 
Repeated exposure to PPL and the subsequent postprandial inflammation (PPI) creates a 
chronic low-grade inflammatory environment2. Specifically, persistent low-grade 
inflammation has been associated with increased risk of cardiovascular disease (CVD)3,4, 
atherosclerosis5,  type II diabetes6, Alzheimer’s disease7, and certain cancers8,9. 
Interestingly, even a single HFM can specific markers of inflammation which include c-
reactive protein (CRP), interleukin-6 (IL-6), interleukin-1B (IL-1ß), and tumor necrosis 
factor-a (TNF-α). Considering these inflammatory markers have been associated with  
increased risk of the previously mentioned chronic diseases in a fasted state, modifying the 
acute increase in these inflammatory markers may lead to a lower overall risk of chronic 
disease development. 
While a HFM transiently increases inflammation, aging also independently 
increases the risk of chronic diseases, in part due to the decreases in immune function 
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(termed immunosenescence)3,52, which occurs naturally with age (i.e. inflammaging). 
There is also an age-related increase in systemic markers of inflammation, including CRP, 
IL-8 and IL-610,11. In addition, there may be a decrease in anti-inflammatory IL-10 with 
aging11 which may be due to decreased muscle mass and ability to secrete anti-
inflammatory cytokines10. Inflammaging, a westernized diet, and reduced anti-
inflammatory capacity may work synergistically to amplify PPI, leading to greater risk of 
inflammation related disease for older adults (OA). 
Fortunately, acute exercise has been utilized as a means to modify the acute 
inflammatory response, likely by altering blood lipid dynamics12, 13 and/or by enabling the 
secretion of anti-inflammatory cytokines through prolonged muscle contraction14. A single 
bout of exercise within 24 of a HFM appears to have the greatest attenuation of PPL in 
young adults (YA)15, however the impact of pre-prandial exercise on PPL remains to be 
elucidated in OA. Therefore, the purpose of this study is to determine whether an acute 
bout of preprandial exercise attenuates the PPI response after a HFM based on age. We 
hypothesize that (1) an acute bout of physical activity will attenuate the postprandial 
inflammatory response in YA and OA and (2) OA will experience a greater attenuation 
from acute exercise than YA. 
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Methods 
Subjects 
12 young adults (YA) between 20-33 yrs (23.3±3.9 yrs, n= 5 M/7 F) and 12 older 
adults (OA) between 62-77 yrs (67.7±6 yrs, n= 8 M/4 F) participated in this investigation. 
Subjects signed an informed consent, completed a physical activity readiness questionnaire 
(PAR-Q),  and the International Physical Activity Questionnaire (I-PAQ) to determine 
chronic physical activity level in MET-minutes/week.  Subject characteristics are displayed 
in table 2. All procedures were approved by the James Madison University Institutional 
Review Board in accordance with the Declaration of Helsinki. 
Experimental Design 
 Each subject completed a total of four laboratory visits. On the first visit, initial 
baseline measures of height, weight, body fat percentage, and blood pressure were taken. 
The subjects then performed an incremental test to volitional exhaustion to determine peak 
oxygen consumption (VO2Peak) and exercise intensity for the acute exercise condition. 
Subjects were then randomly assigned an order to perform two HFM challenges, either the 
HFM alone or exercise + HFM challenge with the  preprandial exercise session occurring 
twelve hours prior to the meal (EX + HFM). Subjects began each experimental trial in the 
morning (starting time; 7:00-11:00 am) after a 12 hour overnight fast with identical starting 
times within subjects. The experimental design is displayed in Figure 1.  
Initial Measurements 
The first laboratory visit was used to collect baseline measurements. Height was 
taken with a stadiometer (Charder Model HM 200P, Charder Electronic Co Ltd., Taichung, 
Taiwan) and weight with a standard physician’s scale (Dymo Pelouze model 4040, Newell 
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Brands, Hoboken, NJ) to calculate body mass index. Following height and weight, a dual-
energy x-ray absorptiometry (DEXA) (GE Lunar iDXA Fairfield, CT) scan was performed 
to calculate lean mass, fat mass, and percent body fat. Resting blood pressure (BP) was 
taken immediately after the DEXA was completed, so that the subject had been resting for 
at least five minutes. BP was measured using an automatic Sphygmomanometer (ProBP 
3400 Welch Allyn, Skaneateles Falls, NY) as detailed in the American College of Sports 
Medicine (ACSM) Guidelines. The average of the two BP measurements were recorded. 
Waist circumference was taken at the narrowest part of the waist with a Gulick tape 
measurer (Creative Health Products, Ann Arbor, MI). 
Incremental Exercise Test 
An incremental cycling test to exhaustion was performed on a VIAsprint 150P 
cycle ergometer (Vyaire Medical, Mettawa, IL) to determine VO2Peak. Breath samples were 
analyzed by a Vmax Encore metabolic cart (Vyaire Medical, Lake Forest, IL), while heart 
rate (HR) was measured by a Polar Link heart rate strap and watch (Polar Lake Success, 
NY). Once the headset, mouthpiece, and nose plug were fitted, the subjects completed a 
five-minute warm up at a self-selected cadence ≥50 revolutions per minute (rpm). During 
the warm up, power output was either increased or decreased every minute until subjects 
identified a workload that they perceived as sustainable for approximately thirty minutes.  
Based on the power output determined during the warm up, one of four potential 
test protocols was chosen (Table 1) in order to reach VO2Peak. Immediately after the warm 
up, the incremental test began, and wattage was set according to stage one of the selected 
protocol. Resistance was increased every minute based on the protocol being used (10 
Watts or 25 Watts). Subjects were verbally encouraged to continue pedaling by the 
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investigators throughout the exercise test. The test was terminated when subjects reached 
volitional exhaustion.  
Food Log and ASA24 Food Recall 
Subjects were given a food log and instructed to record, in detail, all foods and 
beverages consumed the day before their HFM challenge. For the second HFM challenge, 
subjects were asked to duplicate their diet from the previous HFM challenge as closely as 
possible, and once again record in detail their diet for that day.  
Preprandial Exercise Bout 
 During the EX + HFM trial, subjects performed an acute exercise bout twelve hours 
prior to their HFM challenge on the VIAsprint 150P cycle ergometer (Vyaire Medical, 
Mettawa, IL), which was previously used for the VO2peak test. Wattage was set so that the 
subjects’ HR stayed within a HR range that corresponds to 60-70% of their VO2Peak HR, 
for a duration long enough to achieve a total energy expenditure equivalent to 75% of the 
calories of the HFM challenge (Equation 1). However, subjects were not permitted to 
exercise longer than 2-hours which included four OA subjects. There was no caloric 
replacement after the exercise bout due to the potential impact of partial caloric 
replacement on PPL16. 
HFM Composition 
The HFM which consisted of a slice of Marie Callender's Chocolate Satin Pie 
(Conagra Brands, Chicago, IL) portioned out to a caloric density of 12 kcals/kg bw. 
Macronutrient composition of the HFM was 57% fat (57% of which is saturated fat), 4% 
PRO, and 39% CHO.  
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HFM challenge protocol 
After reporting to the lab, subjects were seated in a reclining phlebotomy chair and 
asked to remain sedentary for the duration of the HFM session, except when inside the 
restroom. In the HFM alone condition, subjects were asked to refrain from exercise for at 
least 48 hours prior to their visit to the laboratory. After five minutes, two baseline BP 
measurements was taken with at least 30 seconds of rest between each recording. An 
indwelling safelet catheter was inserted into a forearm vein via a 22-gauge needle (Fisher 
Scientific, Waltham, MA) and kept patent with a 0.9% NaCl solution with a drip rate of 
one/second. A fasting blood draw was taken once the catheter was in place via a 5 mL 
syringe (BD) and emptied into a 6-mL EDTA-coated vacutainer tube.  
Blood samples were drawn every 30 minutes postprandially until the two hour mark 
at which point draws were performed every hour. Plasma (for inflammatory markers), 
blood glucose and lipids (Cardiochek Plus Analyzer, PTS Diagnostics, Indianapolis, IN) 
were tested prior to the HFM challenge. Plasma samples were taken at baseline, 3, and 6 
hours. Blood glucose was tested every 30 minutes up to 2 hours postprandial, and then 
every hour. Blood lipids were tested every hour from baseline until 6 hours post-prandially. 
The experimental protocol is pictured in Figure 1. 
Cytokine Analysis 
After blood draws were transferred to vacutainer tubes, they were immediately 
centrifuged for 12 minutes at 1800 x g in 4 degrees Celsius.  After being separated blood 
plasma was aliquoted into 0.5 ml microtainers and stored for later investigation in a freezer 
at -80 C. All plasma samples were assayed at Eve Technologies (Calgary, Alberta, 
Canada). A Human High Sensitivity T-Cell Discovery Array 14-plex (HDHSTC14) was 
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used to measure IL-6, IL-1β, IL-8, IL-10, and TNF-α. The major pro-inflammatory and 
anti-inflammatory cytokine are the primary focus of this paper, while the remaining 
cytokines were included as an exploratory aim and part of a larger study. Biomarkers were 
analyzed in duplicate and the average measurement was used for analysis.   
Statistical Analysis 
Statistical analyses were done with IBM SPSS Statistics v26.0 (IBM Corporation, 
Armonk, NY). All data were analyzed for normality using the Shapiro-Wilk test. 
Considering baseline TG and baseline inflammation markers passed the Shapiro-Wilk test 
of normality and appeared to be normally distributed upon inspection of central tendency, 
a three-factor analysis of variance was performed with the within-subjects’ factor of time 
(baseline, three, and six hours for cytokines; baseline, two, and four hours for glucose; 
baseline and every hour postprandially up to 6 hours for lipids) and condition (HFM or 
EX+HFM) and the between subjects’ factor of age (YA and OA), and. If significant main 
effects of group or time were detected, data were assessed to determine significance as a 
linear or quadratic function by contrast analysis. Next, post hoc multiple comparisons were 
conducted to test for group- or time-specific differences. In this instance, Bonferroni 
adjustment for multiple comparisons were implemented to avoid type I error. Pearson’s r 
comparisons were also performed to assess associations between PPL and PPI. For all 
analyses, significance was set to p<0.05.  
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Results 
Participant characteristics 
There were no differences in body mass index (BMI) (p=0.454), body fat 
percentage (p=0.158), or absolute VO2Peak (p=0.993) between YA and OA. However, there 
were significant differences in age (p<0.001), weight (p=0.047) and relative VO2Peak (p 
=0.005) between YA and OA. Physical activity level in MET-minutes/week was not 
significantly different between age groups (YA=3,776 MET-min/week ± 3,532, OA=6,157 
MET-min/week ± 5,456) (p=0.262). 
Inflammatory Markers 
Figure 3 displays the cytokine response to the HFM for both groups and both 
conditions. There was no main effect of time x condition across any of the cytokines 
reported at between any timepoints (p >0.05). Figure 3A displays the IL-6 response post-
HFM. There was a time effect for IL-6 (p <0.001), which decreased from baseline to 3 
hours. In examining the change from baseline to 6 hours, the change in IL-6 was significant 
as a quadratic function (p<0.001), where IL-6 decreased by 21 ± 23% at 3 hours but by 53 
± 95% from 3 to 6 hours back to baseline levels. There was no main effect by age (p=0.774) 
and no interaction effects for IL-6 by time x age, time x condition, or time x age x condition 
(all p-values>0.05). Figure 3B displays the IL-8 response post-HFM. There was a 
significant time effect for IL-8 (p<0.001), which was also significant as a quadratic 
function (p<0.001). IL-8 decreased from baseline to 3 hours by 8 ± 20% and increased 
from baseline to 6 hours by 2 ± 25% and increased from 3 to 6 hours by 13 ± 23%. There 
were no significant effects of time x age (p =0.133), time x condition (p =0.259), or of age 
 
27 
 
 
 
x condition (p =0.215). There was no main effect of age (p =0.423). Figure 3C displays the 
IL-10 response post-HFM. There was a significant effect of time for IL-10 (p<0.001), 
which was significant as a quadratic function (p <0.001). IL-10 decreased from baseline to 
3 hours by 9 ± 28% and also decreased from baseline to 6 hours 4 ±26%, however increased 
from 3 to 6 hours by 7 ±28%. There were no interaction effects of time x condition (p 
=0.388), time x age (p =0.357), or in time x condition x age (p =0.641). There was also no 
main effect of IL-10 by age (p =0.746). Figure 3D displays the TNF- α response post-HFM. 
There was a significant main effect of time (p <0.001), which was also significant as a 
quadratic function. TNF- α decreased from baseline to 3 hours by 16.3 ± 19% and baseline 
to 6 hours by 10 ± 24%, however increased from 3 to 6 hours by 9 ± 28%. Where was also 
no interaction in time x condition x age (p =0.538). However, there was a significant 
interaction of time x age (p =0.036), where YA had a greater decrease in TNF- α post-
HFM, with an attenuated decline from baseline to 6 hours when compared to OA (p =0.04). 
OA also had significantly higher TNF- α compared to YA (p =0.047).  
Figure 3E displays the IL1-β response post-HFM. There was a significant main 
effect of time that decreased linearly from baseline to 6 hours (p <0.001). There were no 
interaction effects of time x condition (p =0.485), time x age (p =0.197), or of time x 
condition x age (p =0.355). There was also no main effect of age(p =0.553).  
Metabolic Data 
TG, GLU and LDL are displayed in Figure 4. TG results are displayed from 
baseline to 6 hours post-prandially in Figure 4A. There was a significant time effect for TG 
(p <0.001), which increased from baseline to 6 hours. There was a trend toward a time x 
condition interaction (p =0.06), in the direction of an attenuated increase in TG in the 
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EX+HFM condition. There was also a time x age interaction (p =0.035), where the OA had 
a greater TG response compared to YA, however there was no interaction time x condition 
x age interaction (p =0.714). There was no difference in TG by condition alone between 
HFM and EX+HFM (p =0.278) or in age alone between YA and OA (p =0.187).  
Figure 4B shows LDL hourly post-HFM. There was a significant time effect for 
LDL, where it decreased from baseline to 6 hours post HFM (p =0.001). There was also a 
significant time x age interaction (p <0.001), where the OA had an attenuated decline 
compared to the YA. There was also a trend for a time x condition x age interaction (p 
=0.078), where the OA had greater LDL decline in the EX+HFM condition compared to 
the YA EX+HFM condition. LDL was not different between the HFM alone or EX+HFM 
condition (p =0.870), however LDL was higher in OA compared to YA (p =0.005). 
Post-prandial GLU responses are shown in Figure 4C. There was a significant time 
effect for GLU from baseline to 2 hours post-prandially (p<0.001). There was also a 
significant time x condition interaction (p =0.002), where EX+HFM lowered post-prandial 
glucose compared to the HFM condition alone. There was no time x age or time x condition 
x age interaction between time and age (p =0.690 and p =0.728, respectively). There were 
no main effects for condition or age (p =0.174 and p =0.457, respectively).  
Assosiation Between Metobolic and Inflammatory Markers 
Change in TG from baseline to two hours was weakly, negatively associated with 
change in IL-3 from baseline to three hours (r=-0.31, p=0.034). There was no association 
between TG, GLU, or LDL and any other inflammatory cytokine at any time point either 
in absolute value or change score (p>0.05). HDL was weakly, positively associated with 
IL-1β at baseline (r=0.345, p=0.018) and at 3 hours postprandially (r=0.378, p=0.008). 
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Discussion 
The purpose of this study was to determine whether an acute bout of preprandial 
exercise would attenuate the PPI response to a HFM in YA and OA. We hypothesized that 
(1) an acute bout of physical activity would attenuate the postprandial inflammatory 
response in YA and OA and (2) OA would experience a greater attenuation from acute 
exercise than YA. Considering that the mechanisms linking PPI and postprandial lipemia 
and glycemia remain to be elucidated, an exploratory aim was to assess whether EX had 
an impact on TG and GLU, which could subsequently modify PPI. The results do not 
support our hypotheses. A HFM did not increase any of the reported inflammatory markers. 
Additionally, exercise did not affect the markers of postprandial inflammation that were 
analyzed, although there was a main effect of age for TNF-α.  
IL-6 is the most frequently reported acute phase cytokine. There was no change in 
IL-6 from baseline to six hours. The decrease in IL-6 at three hours was not expected, but 
also not unprecedented in the literature. A study by Emerson and colleagues, conducted 
within several months as the present study and utilizing the same HFM protocol, observed 
a similar quadratic response for IL-611. This IL-6 response was also reported previously in 
a study by Teeman and colleagues in which a HFM of 10 kcals/kg BW and 63% fat was 
used17. However, there are conflicting reports on the effect of a HFM on postprandial IL-
6. Postprandial increases in IL-6 have been reported in studies using relative and absolute 
caloric meal sizes18–20. Dekker and colleagues measured increased IL-6 over the course of 
an 8 hour postprandial period after a 9 kcals/kg BW oral fat tolerance test1. Increases have 
also been reported in HFMs with an absolute caloric size as small at 760 kcals with 59% 
fat19 to as large as 1,416 kcals with 52% fat20. In addition to HFM composition, subject 
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characteristics have also been investigated in their effect on PPI. Changes in postprandial 
IL-6 have not been correlated to BMI, age, or HFM caloric load, but have been shown to 
have a weak negative correlation with the percent fat of a HFM21. The HFM fat percentage 
of the present study falls in between those of studies showing increases in IL-6, thus it is 
hard to say whether or not the correlation between HFM fat percentage and IL-6 is 
supported. IL-6 does play a role in glucose regulation by promoting hepatic glucagon 
secretion22. Perhaps increases in postprandial IL-6 are not influenced by the fat percentage 
of a HFM, but rather the carbohydrate content. HFMs that sacrifice carbohydrate content 
in exchange for greater fat content may promote increased IL-6 during the postprandial 
state to mediate gluconeogenesis rather than inflammatory. All HFM studies are conducted 
after a prolonged fast. If the HFM has only low or moderate carbohydrate content, 
gluconeogenesis would be likely to occur during an extended postprandial period, as the 
subjects have to go for hours without another meal. Another proposed mechanisms for the 
differences in postprandial IL-6 across the literature is based on the diurnal changes in IL-
6. IL-6 has been shown to increase in concentration upon awakening. Because the HFM 
sessions in the present study were all performed in the morning, diurnal changes offer an 
explanation for the decrease in IL-6 at  3 hours postprandially23,24. If baseline 
measurements in the present study were augmented by diurnal changes, a linear increase 
in IL-6 might have been observed if baseline measurements were taken further from the 
time of subject awakening. However, protocols involving morning HFMs are common 
even in experiments that have reported increases in postprandial IL-618–20. Additionally, 
baseline IL-6 levels in the present study were not higher than commonly reported in the 
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literature19, indicating that the proximity of the HFM to subject awakening likely did not 
affect baseline measurements. 
TNF-α decreased from baseline to 6 hours. TNF-α is one of the most frequently 
measured inflammatory markers in PPI research, however according to a recent review by 
Emerson and colleagues, it rarely changes in the postprandial state16. There doesn’t appear 
to be a specific HFM fat percentage or caloric load or subject characteristic that consistently 
elicits an increase in TNF-α, but there is a connection between TNF- α response and IL-6. 
All of the aforementioned studies that elicited increases in IL-6 also reported increases in 
TNF-α18–20, while those with no increase in IL-6 measured decreases in both TNF- α and 
IL-1β11,17, including the present study. Although the inflammation response has not been 
able to be strongly predicted based on meal composition, it appears that the postprandial 
response of IL-6 and TNF-α are linked. The specific meal composition and subject 
characteristics needed to promote an increase in TNF-α need further investigation. 
Downstream pro-inflammatory markers IL-8 and IL-1β decreased from baseline to 
6 hours. These markers are reported infrequently but were measured in the present study 
in an effort to elucidate more details on PPI cytokine dynamics. Due to the decrease in 
TNF-α postprandially, it is not a surprise that the downstream markers followed similar 
trends. IL-10 also decreased at both 3 and 6 hours compared to baseline. This postprandial 
response of IL-10 was also observed by Teeman and colleagues who speculated that the 
decrease in IL-6 might be the reason behind the IL-10 response17. IL-8, IL-1β, and IL-10 
may provide more detailed insight into PPI dynamics and the difference in inflammation 
between YA and OA. However, in the present study it appears that these downstream 
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cytokines simply follow suit with their upstream regulators and may not show any 
independent response to a HFM. 
 Inflammation has been shown to increase during the aging process25. However, the 
results from the present study found that TNF-α was the only inflammatory marker to be 
affected by age.  TNF-α was ~23% higher in OA at baseline compared to YA (p=0.015). 
The decline in postprandial TNF-α was also attenuated by age, by which the decrease in 
TNF-α postprandially was lesser in OA than YA.  Fasting inflammation has been shown 
to increase with age with OA having higher levels of IL-6 and TNF-α over time. In 
longitudinal work by Bartlett and colleagues, inflammation markers were collected 10 
years apart in 249 subjects. After 10 years,  TNF-α and IL-6 were  330% and 130% higher, 
respectively, demonstrating a large increase in inflammation from the aging process. 
However, in the two HFM studies that have investigated YA and OA, no differences in 
TNF-α  or IL-6 by age has been found11,26. The TNF-α results from the present study do 
not agree with the findings from the previous HFM studies by Emerson and colleagues11 
and Milan and colleagues26.  Emerson and colleagues speculated that the amount of dietary 
fiber between groups may have accounted for differences in TNF- α11. Perhaps TNF- α 
concentrations in OA is determinant on a combination factors such as diet, physical activity 
level, and intensity. More research needs to be done on the effect aging has on 
inflammation and the variables that modify age related inflammation. 
 There was no effect of exercise across time points or age groups for any of the 
reported inflammation markers. It is likely that there needs to be PPI in the first place in 
order for exercise to elicit any effect. Exercise is anti-inflammatory14.  Contracting skeletal 
muscle releases IL-6 when glycogen is depleted and mediates  an anti-inflammatory 
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cascade  by increasing IL-10 and actively inhibits TNF-α and IL-1β activity27. Despite our 
understanding of the capacity of exercise to reduce inflammation, exercise has not 
consistently attenuated PPI in HFM studies17,28,29. Various exercise interventions have been 
used across the literature in an attempt to elicit an anti-inflammatory effect on PPI. Previous 
exercise interventions have based exercise duration on different set lengths of time28,30 or 
on absolute kcal energy expenditures29 , all with similar intensities to the present study. 
Unlike previous interventions, the present study used a relative energy expenditure to the 
subject’s HFM kcals to see if a greater effect of exercise could be elicited. Although various 
durations and energy expenditures have been used in an attempt to attenuate PPI, the main 
problem persists that the majority of HFM exercise intervention studies do not use a HFM 
that produces any PPI to begin with. As previously discussed, the magnitude of PPI is 
inconsistent in the literature with some studies reporting either an absence28 or decline30 in 
inflammation and others reporting an increase20. Until a reliable method of inducing PPI is 
found, efforts to investigate the effects of exercise on PPI appear to be tedious.  
 As expected after a HFM, TG and GLU increased in both age groups. OA 
experienced higher postprandial TG, but not GLU. These results are similar to previous 
research investigating postprandial TG and GLU in YA and regularly active OA in which 
active OA experienced greater postprandial TG31.  Regular physical activity in OA has 
been shown to attenuate postprandial glycemia, but not lipemia compared to inactive OA31. 
In a study be Emerson and colleagues, active OA experienced similar postprandial GLU 
levels to active YA, but PPL levels were more similar to inactive OA. The OA in the 
present study may have had activity levels close to those in Emerson and colleagues’ in 
order to attenuate age related change in GLU, but not TG. Exercise attenuated postprandial 
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glycemia at 2 hours in both age groups, but there was only a trend in the effect of exercise 
on TG.  The proposed mechanism behind PPI is dependent on elevated postprandial LDL 
penetrating vascular tissue, however this marker is infrequently reported in HFM studies. 
In the present study, LDL decreased postprandially from baseline to six hours in both age 
groups. In the study by Dekker and colleagues in which increases in IL-6 and TNF-α were 
reported, there was also no change in LDL18. The lack of PPI inducing HFM studies that 
also report on postprandial LDL makes it difficult to draw conclusions on whether or not 
the proposed mechanism of LDL eliciting PPI is supported. Further muddying the 
relationship of LDL to PPI, OA experienced elevated LDL over time compared to YA, 
despite not experiencing a consistent increased PPI response compared to YA. The increase 
in OA LDL could be a result of the trending increase in TG in OA, however this does not 
explain the absence of PPI. There is little support for the association between TG and 
PPI28,32. In the present study, TG were not associated with any inflammatory marker. 
Furthermore, there was also no association between inflammation and  GLU. Evidence 
suggests that TG and GLU are not the mediators of a PPI response in the typical HFM 
challenge. Further research needs to be done to determine if an alternate metabolic marker 
is associated with PPI.  
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Conclusion 
Our findings question the direct role that HFMs and a western diet play in chronic 
inflammatory related diseases.  Despite the use of a large HFM that was also high in 
saturated fats, no PPI was detected in either age group. The growing body of literature that 
has failed to induce PPI after a HFM increases doubt behind the connection of a single 
HFM increasing the risk of inflammation related diseases. Investigation into meal timing 
and multiple HFM spaced throughout the day may lead to answers on how diet and 
behavior work together to promote inflammation and disease. Further research needs to be 
done to elucidate the root cause of PPI to be able to consistently produce a PPI state in 
experimental trials. Additionally, more work needs to be done to determine whether or not 
exercise truly does have a protective effect in PPI and the proper exercise protocols to 
generate such effect. 
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Table 1. Protocols for incremental VO2peak cycle ergometer test based on subject 
determined warm up wattage. 
 Protocol A Protocol B Protocol C Protocol D 
Warm up 
Wattage 
≤ 25 25-50 50-75 ≥75 
Stage 1 
(Watts) 
25 25 50 75 
Stage 2 
(Watts) 
35 50 75 100 
Additional 
Stages 
10 W increases 25 W increases 25 W increases 25 W increases 
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𝑏𝑤𝑘𝑔 ∗ 12.5 𝑘𝑐𝑎𝑙𝑠 ∗ 0.75
𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑉𝑂2 ∗ 4.825𝐿 𝑂2 𝑘𝑐𝑎𝑙⁄ ∗ 0.65
 
Figure 1. Determining exercise duration sufficient to burn 75% of the calories from the 
HFM. 
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Figure 2. Protocol for the HFM sessions. Time increments are in minutes. P: plasma 
collected for inflammation markers, G: glucose collected; L: lipids collected. Satiety 
collected via SLIM scale.  
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Table 2. Participant characteristics   
  YA OA    
  (7F/5M) (4F/8M) P value 
Age (years) 23.3 ± 3.9 67.6 ± 6* <0.000 
Height (cm) 167.5 ± 8.1 175.9 ± 8.6 0.22 
Weight (kg) 71.4 ± 16.9 80.7 ± 14.7* 0.047 
Body mass index (BMI) (kg/m2) 25.3 ± 5.0 26.7 ± 4.3 0.454 
Body Fat (%) 28.2 ± 8.7 33.1 ± 6.5 0.158 
Absolute VO2peak (L/min) 2.3 ± 0.4 2.3 ± 0.8 0.993 
Relative VO2peak (mL/kg/min) 33.4 ± 5.3 28.3 ± 6.7* 0.005 
MET-minutes per week 3,776 ± 3,532 6,157 ± 5,456 0.262 
* Signifies p<0.05 compared to YA.           
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Table 3. High fat meal (HFM) composition and exercise session calculations for YA and OA. 
Exercise duration was capped at two hours, there were three OA participants whose calculated 
exercise duration exceeded the two hour cap. 
 YA  OA    
 (7F/5M) (4F/8M) P value 
HFM Calories 856.8 ± 207.1 968.8 ± 180.8 0.172 
HFM Total Fat Calories 488.3 ± 118.1 552.2 ± 103.0 0.172 
HFM Saturated Fat Calories 278.4 ± 67 314.8 ± 58.8 0.172 
HFM CHO Calories 334.1 ± 80.8 377.8 ± 70.3 0.172 
Exercise Energy Expenditure (kcals) 642.6 ± 155.4 726.6 ± 135.6 0.172 
Exercise Session Duration (minutes) 88.1 ± 15.1 102.3 ± 18.4 0.053 
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Figure 4. Metabolic response to HFM and EX+HFM in YA and OA. (a) triglycerides, 
(b) LDL, (c) blood glucose. Dashed lines and empty markers indicated EX+HFM, solid 
lines and filled markers indicate HFM, triangles indicate YA and circles indicate Older 
adults. * Indicates within group significance compared to baseline. ⱡ Indicates between 
group significance for age. # Indicates significance by condition. Error bars indicate 
95% CI. Significance set at p<0.05 
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Figure 3. Cytokine response to HFM and EX+HFM in YA and OA at baseline, 3 
hours, and 6 hours postprandially. (a) IL-6, (b) IL-8, (c) IL-10, (d) IL-1β, (e) TNFα. 
Dashed lines and empty markers indicated EX+HFM, solid lines and filled markers 
indicate HFM, triangles indicate YA and circles indicate Older adults. * Indicates 
within group significance compared to baseline. ⱡ Indicates between group significance 
for age. # Indicates significance by condition. † Indicates significance by age and 
condition. Error bars indicate 95% CI. Significance set at p<0.05 
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Appendices 
Does acute preprandial exercise modify postprandial inflammation after a high fat 
meal in young and older adults? 
Consent to Participate in Research 
Identification of Investigators & Purpose of the Study   
You are being asked to participate in a research study conducted by Drs. Stephanie Kurti 
and Elizabeth Edwards from James Madison University.  To participate, you must be in 
good health and able to exercise (per the physical activity readiness-questionnaire and 
medical records). The purpose of this study is to determine whether being active impacts 
how your body responds to a high-fat meal.  Previous research tells us that this response 
after a meal is actually a more accurate prediction of your disease risk than fasting levels.  
We also want to see if how active you are on a regular basis changes how your body 
responds to a high-fat meal.  This study will contribute to the knowledge of both 
practitioners and clinicians, and may provide an important public health message in 
promoting exercise as a way to affect how your body responds to high-fat meals, without 
the need for prescription drugs.  Should you decide to participate in this research study, 
you will be asked to sign this consent form once all your questions have been answered to 
your satisfaction.   
Research Procedures 
This study consists of a series of surveys, a body composition scan, and fitness test that 
will be administered to individual participants in the Human Performance Laboratory at 
James Madison University. There will be one acute exercise session and two meal sessions. 
The total time required for participation in the research study is outlined on the following 
page (time required section). The specific procedures during each visit are included here: 
 
Initial visit:  If you are older, you will have already have had to receive medical 
clearance from your physician to participate in this study prior to your initial visit. On the 
first visit to the laboratory, you will be briefed on the study and asked to complete a series 
of questionnaires, including the international physical activity questionnaire, the physical 
activity readiness-questionnaire plus, and a medical history form. If you’d like to see any 
of these questionnaires prior to consenting, please ask a researcher and we’ll be happy to 
provide one for you.  
On this first day, you’ll also undergo a few tests. First, we’ll assess your height and 
weight. Then we’ll perform a DEXA scan to assess your body composition scan (how much 
of your body is fat vs. lean mass). Finally, you’ll perform an exercise test on a cycle 
ergometer. The exercise test is a test to assess your peak aerobic capacity, which is the best 
measure of cardiorespiratory fitness. The exercise bout lasts approximately 12 to 15 
minutes until you need to stop or cannot maintain the required cadence. Before and after 
the exercise testing, standard pulmonary function tests (PFTs) will be performed, which 
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will be repeated at 2 minutes and 20 minutes after the bout of exercise. These tests are 
noninvasive and commonly used to assess the capacity of the pulmonary system. An 
example of these tests are a breathing maneuver simply requires you to maximally inhale, 
then forcefully exhale and hold for 6 seconds, and then to maximally inhale again.  
Following the measurements and exercise testing, you will be given an 
accelerometer to wear for one week and will return to the laboratory for your second testing 
session after the one-week period. Your next visit will either be a meal testing session with 
exercise the night before or a meal testing session without exercise the night before.  
Meal testing sessions: Your HFM testing sessions will be after a 12 hour 
fast.  We’ll place an indwelling intravenous catheter inserted into a forearm vein to allow 
for repeated blood draws. You will be asked to perform several experimental measurements 
prior to consumption of a single high-fat meal (Marie Callender’s Chocolate Satin Pie, 63% 
fat, 12 kcal/kg body weight). The meals contain dairy and gluten. These same 
measurements will be performed every hour until 6 hours after the HFM. These include 
the following: Pulmonary function testing, exhaled nitric oxide, exhaled breath condensate, 
blood draws for glucose, triglycerides, and inflammatory and angiogenic markers.  
Acute exercise session: On the day that you’re completing the exercise, you’ll 
come to the lab 12 hours prior to your meal testing session.  At this session, you will 
exercise long enough to expend 75% of the calories that will be consumed in the HFM 
session. You will exercise on a cycle ergometer at a moderate intensity at 65% of your 
VO2peak (which will be based on the cycle test from the first day). Throughout this exercise 
session, heart rate data will be monitored continuously.  
Blood sample Storage: After collection, your blood will be stored in a deep freezer 
on JMU’s campus until all samples have been collected.  At that point, the blood will either 
be analyzed here at JMU or shipped off to partner labs (e.g. UVA or EVE Technologies) 
for analysis there.  Any blood shipped to partner sites will be destroyed or returned after 
those analyses are complete. 
Time Required 
Participation in this study will require about 18 hours of your time over the course 
of 4 separate visits.  Upon completion of the study, you will be compensated $75.00 upon 
completion of the study. The visits are outlined below:  
Baseline Testing: On the first visit to the laboratory, completing the required forms 
and questionnaires, performing the acute exercise test, and undergoing the body 
composition scan will take approximately 2 hours. 
HFM Visits: Two HFM sessions will each be ~7 hours in length. During this time, 
an intravenous catheter will be inserted into the median cubital vein of the forearm and 
blood samples will be obtained before the HFM and every hour post-meal for 6 
hours.  Approximately 10ml of blood will be obtained during each time-point post-HFM.  
The catheter will be kept patent by a slow, continuous flow (1 drop/second) of saline 
solution. The catheter will remain in the antecubital vein of the participant for the 
remainder of the measurement period in order to prevent clotting in the catheter (thus 
allowing a single venipuncture for multiple blood samples). The following variables will 
be analyzed from these samples: triglycerides, glucose, insulin, angiogenic and 
inflammatory markers.  
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Acute exercise session: This session will involve an acute bout of exercise that 
should last between 30-45 minutes, however may vary from person to person. The exercise 
bout will not last longer than 90 minutes in any individual.  
 
Risks  
Participation in this study does have some risks, although they are small. The risk 
of any serious event during this study is very small.  Possible risks include: 
 Catheter:  You may experience discomfort with the placement of the catheter. The 
catheter is plastic tubing and allows the arm to be moved throughout the 6-hour testing 
session. If excessive discomfort exists, the catheter can be taken out at any time during the 
study.  
Exercise bout: Both the baseline exercise test and the exercise bout may be 
associated with some discomfort and soreness on the following days.  This is a normal 
physiological response and is not dangerous.  During the exercise test, you will have a 
mouthpiece in for the duration of the test. This may be uncomfortable and you may 
withdraw from the study at any time. Supervision will be provided by research assistants 
trained in CPR and AED to minimize any potential risk from the exercise bout. Also, your 
heart rate, ventilatory and metabolic data will be continually monitored throughout the 
entire exercise bout. If any aberrant responses are recorded, investigators will ask you to 
discontinue the exercise.  
High-fat meal: The high-fat meal protocol is of very short duration, and any 
changes in blood lipids, glucose, or inflammatory markers are unlikely to create any long-
term health problems.  Additionally, this meal is not out of line with meals consumed on a 
regular basis by a significant portion of the US population. 
DEXA: The DEXA scan entails a low dose of radiation equivalent to 
approximately one transatlantic flight (0.015 mSv= millisievert). While there is no 
validated questionnaire to define extensive exposure, increased radiation correlates with 
increased risk of cancer and consequently, increased risk of death.  However, for reference, 
the annual permissible dose for a radiation worker is 5,000 mrem or 5 rem, - which would 
be over 3,000 of these scans in one year. The limit for a pregnant worker, the most 
conservative level given, is 500mrem - over 300x the dose we are using. 
 
Benefits 
By participating in this study, you will learn about your current level of valuable 
blood, body composition, and pulmonary values. Your data will be provided to you upon 
completion of your participation in the study. If an emergency arises and you must drop 
out, you may still receive your data. Having these tests done in a lab would cost several 
hundreds of dollars.  Additionally, you will be compensated $75 via a JMU Prepaid gift 
card for your time during the study. 
Society may benefit from more knowledge about how lifestyle affects the 
inflammatory, lipemic and angiogenic response to a high-fat meal, which is associated with 
cancer and cardiopulmonary disease development. Additionally, society will learn whether 
acute exercise is an effective method in older adults to attenuate these deleterious 
postprandial responses.   
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Confidentiality  
The results of this research will be presented at the American College of Sports 
Medicine Annual meeting as well as the Experimental Biology annual conference. The 
results of this project will be coded in such a way that the respondent’s identity will not be 
attached to the final form of this study.  The researcher retains the right to use and publish 
non-identifiable data.  While individual responses are confidential, aggregate data will be 
presented representing averages or generalizations about the responses as a whole.  All data 
will be stored in a secure location accessible only to the JMU researchers.  Upon 
completion of the study, all information that matches up individual respondents with their 
answers will be destroyed.  
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  
Should you choose to participate, you can withdraw at any time without consequences of 
any kind. 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or 
after its completion or you would like to receive a copy of the final aggregate results of this 
study, please contact: 
Researcher’s Name: Dr. Stephanie Kurti  Department of Kinesiology   
Email Address: kurtisp@jmu.edu   James Madison University 
Cell-Phone number: 630-205-6363   Office Telephone:  540-568-3947 
 
Researcher’s Name: Dr. Elizabeth Edwards  Department of Kinesiology 
E-mail Address: edwardes@jmu.edu   James Madison University 
Office Telephone: 540-568-5220 
Questions about Your Rights as a Research Subject 
Dr. Taimi Castle      Chair, Institutional Review Board 
(540) 568-5929     James Madison University 
castletl@jmu.edu 
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a 
participant in this study.  I freely consent to participate.  I have been given satisfactory 
answers to my questions.  The investigator provided me with a copy of this form.  I certify 
that I am at least 18 years of age. 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                    Date 
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______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
 
 
 
 
 
 
 
 
Attn. Dr. _______ 
 
Your patient needs the following physician approval to participate in our JMU research 
project.  
     
Physician Approval Form 
 
Patient Name:  ___________________________       
  
 
Project Description:  
The purpose of the study is to investigate to determine whether an acute bout of moderate-
intensity exercise will attenuate the lipemic response to a high-fat meal in active and 
inactive older adults. We hypothesize that an acute bout of moderate-intensity exercise will 
attenuate the lipemic response to a high-fat meal in active and inactive older adults, with a 
greater attenuation of the lipemic response in the inactive older adults. 
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When the participant arrives at the laboratory, we will take resting blood pressure and heart 
rate, and several pulmonary function tests. These will be performed before and after an 
exercise test. The exercise test is performed on a cycle ergometer, where the intensity will 
increase every minute by 10-25 watts until volitional exhaustion (it is too hard to turn the 
pedals). We monitor heart rate, oxygen saturation, and blood pressure throughout the 
exercise test.  
 
Usually the test lasts ~10 minutes, with only 1 or 2 minutes of very hard work, until the 
participant wishes to stop the test. All researchers are trained in CPR and our laboratory 
has an AED present. We have tested ~50 participants thus far, and nobody has had any 
issues during or after the exercise test to fatigue.  
 
We are using American College of Sports Medicine guidelines to determine whether 
participants are eligible for participation in the research project. If the individual does not 
have a previous heart condition, chest pain when they currently exercise, and is not on any 
heart medications, they are able to participate in the test without medical supervision.  
 
However if they have not been exercising recently we ask for physician approval to 
participate in the research study. The participant can stop whenever they want during the 
test if they feel uncomfortable. Maximal oxygen consumption is the best measure of fitness 
level and overall health, and we will discuss the results with them after their session.  
 
Contact: Hannah Frick (frickh1@jmu.edu: (c) 703-638-8892) or Scott Wisseman 
(wissemws@dukes.jmu.edu: (c) 703-268-9976) if you have any questions. 
 
Our departmental fax number is: 540-568-3338 
 
I have reviewed the project description and believe the individual is able to complete a 
maximal exercise test for the research project. 
 
Printed Name: _________________________________  Date: ___________ 
 
Signed Name: ___________________________________   
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Additional notes:  
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
(October 2002) 
 
LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 questionnaires. 
Long (5 activity domains asked independently) and short (4 generic items) versions for use by 
either telephone or self-administered methods are available. The purpose of the questionnaires is 
to provide common instruments that can be used to obtain internationally comparable data on 
health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in Geneva in 1998 
and was followed by extensive reliability and validity testing undertaken across 12 countries (14 
sites) during 2000. The final results suggest that these measures have acceptable measurement 
properties for use in many settings and in different languages, and are suitable for national 
population-based prevalence studies of participation in physical activity. 
 
Using IPAQ  
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this will affect 
the psychometric properties of the instruments.  
 
Translation from English and Cultural Adaptation 
Translation from English is encouraged to facilitate worldwide use of IPAQ. Information on the 
availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If a new translation 
is undertaken we highly recommend using the prescribed back translation methods available on 
the IPAQ website. If possible please consider making your translated version of IPAQ available 
to others by contributing it to the IPAQ website. Further details on translation and cultural 
adaptation can be downloaded from the website. 
 
Further Developments of IPAQ  
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website.  
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More Information 
More detailed information on the IPAQ process and the research methods used in the development 
of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000). Assessment of 
Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2): 
s114-20. Other scientific publications and presentations on the use of IPAQ are summarized on 
the website. 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of their 
everyday lives. The questions will ask you about the time you spent being physically active in the 
last 7 days. Please answer each question even if you do not consider yourself to be an active 
person. Please think about the activities you do at work, as part of your house and yard work, to 
get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous and moderate activities that you did in the last 7 days. Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe much 
harder than normal. Moderate activities refer to activities that take moderate physical effort and 
make you breathe somewhat harder than normal. 
 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, course 
work, and any other unpaid work that you did outside your home. Do not include unpaid work you 
might do around your home, like housework, yard work, general maintenance, and caring for your 
family. These are asked in Part 3. 
 
1. Do you currently have a job or do any unpaid work outside your home? 
 
  Yes 
 
 No Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part of your paid 
or unpaid work. This does not include traveling to and from work. 
2.  During the last 7 days, on how many days did you do vigorous physical activities like 
heavy lifting, digging, heavy construction, or climbing up stairs as part of your work? 
Think about only those physical activities that you did for at least 10 minutes at a time. 
 
_____ days per week 
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 No vigorous job-related physical activity Skip to question 4 
 
3. How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
4. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate physical activities 
like carrying light loads as part of your work? Please do not include walking. 
 
_____ days per week 
 
 No moderate job-related physical activity Skip to question 6 
 
5. How much time did you usually spend on one of those days doing moderate physical 
activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
6. During the last 7 days, on how many days did you walk for at least 10 minutes at a time 
as part of your work? Please do not count any walking you did to travel to or from work. 
 
_____ days per week 
 
 No job-related walking Skip to PART 2: TRANSPORTATION 
 
7. How much time did you usually spend on one of those days walking as part of your work? 
 
_____ hours per day 
_____ minutes per day 
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PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places like work, 
stores, movies, and so on. 
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like a train, 
bus, car, or tram? 
 
_____ days per week 
 
 No traveling in a motor vehicle Skip to question 10 
 
9. How much time did you usually spend on one of those days traveling in a train, bus, car, 
tram, or other kind of motor vehicle? 
 
_____ hours per day 
_____ minutes per day 
 
Now think only about the bicycling and walking you might have done to travel to and from work, 
to do errands, or to go from place to place. 
 
10. During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time 
to go from place to place? 
 
_____ days per week 
 
 No bicycling from place to place Skip to question 12 
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11. How much time did you usually spend on one of those days to bicycle from place to place? 
 
_____ hours per day 
_____ minutes per day 
 
12. During the last 7 days, on how many days did you walk for at least 10 minutes at a time 
to go from place to place? 
 
_____ days per week 
 
 No walking from place to place Skip to PART 3: HOUSEWORK, 
HOUSE MAINTENANCE, AND 
CARING FOR FAMILY 
 
13. How much time did you usually spend on one of those days walking from place to place? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
 
This section is about some of the physical activities you might have done in the last 7 days in and 
around your home, like housework, gardening, yard work, general maintenance work, and caring 
for your family. 
 
14. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like 
heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard? 
 
_____ days per week 
 
 No vigorous activity in garden or yard Skip to question 16 
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15. How much time did you usually spend on one of those days doing vigorous physical 
activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
16. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate activities like 
carrying light loads, sweeping, washing windows, and raking in the garden or yard? 
 
_____ days per week 
 
 No moderate activity in garden or yard Skip to question 18 
 
17. How much time did you usually spend on one of those days doing moderate physical 
activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
18. Once again, think about only those physical activities that you did for at least 10 minutes 
at a time. During the last 7 days, on how many days did you do moderate activities like 
carrying light loads, washing windows, scrubbing floors and sweeping inside your home? 
 
_____ days per week 
 
 No moderate activity inside home Skip to PART 4: RECREATION, 
SPORT AND LEISURE-TIME 
PHYSICAL ACTIVITY 
 
19. How much time did you usually spend on one of those days doing moderate physical 
activities inside your home? 
 
_____ hours per day 
_____ minutes per day 
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PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
 
This section is about all the physical activities that you did in the last 7 days solely for recreation, 
sport, exercise or leisure. Please do not include any activities you have already mentioned. 
 
20. Not counting any walking you have already mentioned, during the last 7 days, on how 
many days did you walk for at least 10 minutes at a time in your leisure time? 
 
_____ days per week 
 
 No walking in leisure time Skip to question 22 
 
21. How much time did you usually spend on one of those days walking in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
22. Think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do vigorous physical activities like 
aerobics, running, fast bicycling, or fast swimming in your leisure time? 
 
_____ days per week 
 
 No vigorous activity in leisure time Skip to question 24 
 
23. How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
24. Again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate physical activities 
like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your 
leisure time? 
 
_____ days per week 
 
64 
 
 
 
 
 No moderate activity in leisure time Skip to PART 5: TIME SPENT 
SITTING 
 
25. How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
 
PART 5: TIME SPENT SITTING 
 
The last questions are about the time you spend sitting while at work, at home, while doing course 
work and during leisure time. This may include time spent sitting at a desk, visiting friends, reading 
or sitting or lying down to watch television. Do not include any time spent sitting in a motor vehicle 
that you have already told me about. 
 
26. During the last 7 days, how much time did you usually spend sitting on a weekday? 
 
_____ hours per day 
_____ minutes per day 
 
27. During the last 7 days, how much time did you usually spend sitting on a weekend day? 
 
_____ hours per day 
_____ minutes per day 
 
 
This is the end of the questionnaire, thank you for participating. 
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Food Intake Record Directions and Tips 
You will have to input all the food that you consume in a day into a nutrition database at 
your first and second testing sessions. Also, your food consumption should be the same on both 
days before your high-fat meal session.  
We will give you a copy of the food that you have consumed so you can remember what to 
eat the next time before visiting the laboratory. 
Instructions on Use: 
• In the first two columns, note the time and location the food or beverage was consumed. 
• In the third column, record the food or beverage consumed. 
o Be as detailed as possible in describing the food item. For example not just chicken, but 
how it was prepared (fried, grilled, baked, etc.) and include any sauces or dressings put on 
any food item. If you eat a salad, try and write own everything that was in the salad with 
appropriate portion sizes.  
o Include brand names or restaurant names with the item names whenever possible. 
Examples: Kraft, General Mills, Campbell’s’ McDonalds 6 piece McNuggets, etc. 
o Include toppings such as mustard, ketchup, mayo, cream sugar, steak sauce, salsa, dressing, 
gravy, etc. 
o If you are at a restaurant, it is more than OK to ask the staff or waiter/waitress how 
something was prepared or about the ingredients in a particular item. Additionally, if you 
want, you can include the description off the menu. 
o If you have a recipe or a label of a common food you consume, feel free to bring it in. The 
more detail you can provide, the better analysis we can provide. 
• Determine serving size for food and beverage (columns 4-6): 
o Portion Size: How many?: How many of this item did you consume? 
o Portion Size: Food Model: Estimate the size of your food. Options: 
▪ Use the Food Amounts Booklet as a visual guide. 
▪ OR if you’re cooking at home and you know the measured amount, include the 
measurements. You can use household measures such as measuring cups and spoons 
to further help you estimate how much you consumed. 
▪ OR if a weight from the package is available, include the weight. 
▪ Notes: Leave this blank unless there is something you would like us to know.  
• Remember to include all beverages (even water) and snacks consumed.  
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• Be as honest as possible! This really helps with the accuracy of the data that is collected. We 
are simply trying to document what you consumed of the recording period. 
• If you have any questions please contact a researcher. 
• Thank you again for your participation. Your accuracy not only assists us with our research, 
but provides us a great tool for understanding the impact on your nutrition on several of the 
responses to the exercise and acute high-fat feeding sessions.  
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ID _________   AC ___________  m0 
 
 Using Your Activity Monitor 
Thank you for agreeing to wear this Activity Monitor. The Activity Monitor is attached to a black 
belt with a clasping buckle that you will put around your waist like a belt. These instructions are 
intended to help you get started wearing your Activity Monitor. A phone number is provided at 
the end of these instructions should you need to contact us.  
Checklist 
1. Read all materials in this packet. These instructions contain important information 
regarding the proper use of your Activity Monitor. 
2. Begin wearing the monitor when you wake up on the Requested Start Date. The 
monitor will start working automatically – you DO NOT need to activate it. 
3. Wear the monitor during all waking hours for the seven requested days.  
4. Stop wearing the monitor at the end of the day on the Requested End Date.  
5. For each day you wear the unit, record the exact time of day you put it on, the exact 
time you took it off, and any time you did not wear the unit on your Accelerometer 
Log.  
6. After you have worn the Monitor for seven days, place it back in the padded envelope 
and mail it back to us with the completed activity log. 
 
 
 
 
When to Wear the Activity Monitor 
• First, consult the Accelerometer Log form for the actual dates that you should be 
wearing your Activity Monitor. 
• The total time you will be wearing the Activity Monitor will be seven days. 
• You should wear it throughout the entire day. We cannot use the data if the monitor 
has not been worn during all waking hours. The only times you should NOT wear the 
monitor are: 
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o While you are sleeping 
o When you shower, bathe, or swim (water will damage it) 
• We would like you to wear the monitor for the seven days indicated on the 
Accelerometer Log. (See example below.) However, if you are unable to start wearing 
the monitor on the requested start date, or you forget to wear it on one of the 
requested days, you should continue wearing the monitor until you have worn it for 
seven full days. 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Date 11/28 11/29 11/30 12/1 12/3 12/4 12/5 
Time of day you 
put on the unit 
6:35 am 7:20 am 7:45 am 7:25 am 5:50 am 6:15 am 6:50 am 
Time of day you 
took  off the unit 
8:25 pm 9:40 pm 9:25 pm 9:00 pm 8:35 pm 8:15 pm 8:55 pm 
Any time you did 
not wear the unit? 
(e.g. naps, bathing) 
 
------- 
12:30 -
12:50 pm 
6:00-6:50 
pm 
 
------- 
 
-------- 
9:15-9:40 
am 
 
------- 
Please provide comments about problems that occurred while you were wearing the unit. 
I forgot to wear the monitor on 12/2, so I wore it on 12/5 instead. 
 
How to Wear the Activity Monitor 
The Activity Monitor is already attached to a belt that you will wear around your waist. 
Following these step-by-step instructions should help you begin wearing your Activity 
Monitor: 
1. Taking the belt, place it around your waist so that the arrow on the Activity Monitor 
is facing away from you and is pointed up towards your head, as in the picture below: 
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2. Take both ends of the buckle and connect them so that the belt is attached loosely 
around your waist. 
3. You may adjust the tightness of the belt by pulling on the straps to make it tighter or 
by pulling on the back of the buckle to make it looser. Your belt should be snug, but 
not uncomfortably tight. (See “Caring for the Activity Monitor” if you need to make 
alterations to your belt.) You may wear the monitor over or under your clothing. 
4. The activity monitor should be worn on your left hip. The Activity Monitor should 
slide into place along the belt with gentle pressure.  
 
 
 
 
 
 
Caring for the Activity Monitor  
• You will probably not need to clean the Activity Monitor. If it gets dirty, however, 
simply wiping it with a damp (not wet) rag should be sufficient. 
• If after tightening your belt, there is a lot of excess belt hanging from the buckle, you 
may wish to trim it back. To do so, you should: 
o Make sure to leave about 3-4 inches excess for adjustment purposes. 
o Cut the belt evenly with a pair of scissors. 
o Seal the cut end of the belt with some clear nail polish to prevent fraying (if 
necessary). 
• You may use a safety pin or rubber band to tie up extra belt rather than cutting it if 
you prefer. 
Other important notes about your activity monitor: 
• This piece of equipment is very expensive, so please take good care of it! 
• The Activity Monitor is not waterproof, so please avoid getting it wet, as this could 
cause damage. 
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• The Activity Monitor may or may not flash. Either way, it is not a cause for any 
concern. Trust us – it’s working! 
 
 
 
 
 
Returning the Activity Monitor 
After you have worn the Activity Monitor for a full week, we ask that you return it to us so 
that we can collect the data and use it for other participants. When returning the Activity 
Monitor to us, you should: 
• Remove the Activity Monitor from your waist. 
• Remember to record your actual end date on the Accelerometer Log and ensure the 
rest of the form is complete. 
• Wrap the belt around the Activity Monitor and hold secure with a rubber band. 
• Place the Activity Monitor back in the padded envelope and mail it back to us with 
the completed Accelerometer Log. 
Activity Monitor Troubleshooting 
If you are experiencing problems with your Activity Monitor or have questions, please 
contact study coordinator Stephanie Kurti and kurtisp@jmu.edu or 630-205-6363.  
 
 Frequently Asked Questions 
My activity monitor was blinking and then stopped. Is it still working? Yes, some of the 
monitors blink before they start recording activity but some of our newer versions don’t blink at 
all. Either way, keep wearing your monitor.  
I don’t want the monitor to show when I wear it. Can I wear it underneath my clothes? Yes, 
you can wear it over or under your clothes – whatever is most comfortable for you. 
My activity monitor seems to ride up and won’t stay on my hip. Some people have said they 
have this issue. It will still record but it’s better to have it closer to your hip if possible. You can 
try tightening it, pinning the band to your pants, or running the band through your belt loops.  
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I accidentally wore the monitor upside down one day. Do I need to wear it for an extra day? 
No, as long as you wore the monitor during all of your waking hours you do not need to wear it 
for an extra day. The data it collects are still accurate even if it’s upside down.  
I forgot to put on my monitor and then went out for the morning. Should I wear it for the 
afternoon/evening or just skip today? It is very important that you wear the monitor for the 
entire day. If you forget to wear it for part of the day, it is best to skip that day and add an extra 
full day to the end instead. Be sure to record this on your log.  
My schedule for the week I’m supposed to wear the monitor is not a normal week for me. 
Should I still wear it? Yes. The important thing is that you wear it during the time we have 
specified. If needed you can make note of any special circumstances on your log. 
I am going to be traveling when I’m supposed to wear my monitor. Will I be able to go 
through security at the airport? Yes. You will need to take it off just as you do your jewelry. 
The x-ray will not harm the device.  
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ID _________   AC ___________  m0 
 
 Activity Monitor Log 
As a participant in this program, we ask that you wear your Activity Monitor for one week. Begin 
wearing the monitor on the Requested Start Date. Please try to wear the monitor for seven 
consecutive days, but if you do need to skip a day for any reason, continue wearing it until you 
have worn it for a full seven days.   
Requested Start Date:     /       / 18       When you get up in the morning 
Requested End Date:        /      / 18    When you go to bed at night 
Please record the actual dates/times you wore the accelerometer in the table below. Please be as 
precise as possible in reporting the times you put on and removed the monitor. 
 Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Date        
Time of day you put on 
the unit 
       
Time of day you took 
off the unit 
       
Any time you did not 
wear the unit? 
(e.g. naps, bathing) 
       
Please provide comments about problems that occurred while you were wearing the unit. 
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